Pharmacological exploration of the sedative mechanism of hesperidin identified as the active principle of Citrus sinensis flowers

Planta Medica

Volumn 75, Issue 4, 2009, Pages 295-301

  Guzmán Gutiérrez, Silvia Laura ^a   Navarrete, Andrés ^a  

^a Universidad Nacional Autonoma de Mexico Facultad de Quimica   (Mexico)

Author keywords

Adenosine; Citrus sinensis; Hesperidin; Insomnia; Mexican traditional medicine; Rutaceae; Sedative plants

Indexed keywords

8 PHENYLTHEOPHYLLINE; AMINOPHYLLINE; ATROPINE; BUSPIRONE; CAFFEINE; CITRUS SINENSIS EXTRACT; CLONIDINE; DICHLOROMETHANE; FENCLONINE; FLUMAZENIL; FORSKOLIN; HALOPERIDOL; HESPERIDIN; ISOPRENALINE; METHANOL; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PLANT EXTRACT; ROLIPRAM; SEDATIVE AGENT; UNCLASSIFIED DRUG; YOHIMBINE; HYPNOTIC SEDATIVE AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG POTENTIATION; FLOWER; MALE; MOUSE; NONHUMAN; SWEET ORANGE; ANIMAL; CHEMISTRY; MEXICO; TRADITIONAL MEDICINE;

CITRUS; CITRUS SINENSIS; MUS; RUTACEAE;

ANIMALS; CITRUS SINENSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FLOWERS; HESPERIDIN; HYPNOTICS AND SEDATIVES; MALE; MEDICINE, TRADITIONAL; MEXICO; MICE;

EID: 65649122964     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1185306     Document Type: Article

References (31)

1. Nau SD, McCrae CS, Cook KG, Lichstein KL. Treatment of insomnia in older adults. Clin Psychol Rev 2005; 25: 645-672
2. Roth T. New developments for treating sleep disorders. J Clin Psychiatry 2001; 62 (Suppl. 10): 3-4 (Pubitemid 32476534)
3. Kamel NS, Gammack JK. Insomnia in the elderly: cause, approach, and treatment. Am J Med 2006; 119: 463-469
4. Benca RM. Diagnosis and treatment of chronic insomnia: a review. Psychiatr Serv 2005; 56: 332-343 (Pubitemid 40333567)
5. Gottesmann C. GABA mechanisms and sleep. Neuroscience 2002; 111: 231-239
6. Wheatley D. Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability. J Psychopharmacol 2005; 19: 414-421 (Pubitemid 41003139)
7. Marder M, Viola H, Wasowski C, Fernández S, Medina JH, Paladini AC. 6-Methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS. Pharmacol Biochem Behav 2003; 75: 537-545 (Pubitemid 36936888)
8. Garg A, Garg S, Zaneveld LJD, Sinlge AK. Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytother Res 2001; 15: 655-669 (Pubitemid 34016792)
9. Loscalzo LM, Wasowski C, Paladini AC, Marder M. Opioid receptors are involved in the sedative and antinociceptive effects of hesperidin as well as in its potentiation with benzodiazepines. Eur J Pharmacol 2008; 580: 306-313
10. Tortoriello J, Romero O. Plants used by Mexican traditional medicine with presumable sedative properties: an ethnobotanical approach. Arch Med Res 1992; 23: 111-116 (Pubitemid 23196696)
11. Carvalho-Freitas MIR, Costa M. Anxiolytic and sedative effects of extracts and essential oil from Citrus aurantium L. Biol Pharm Bull 2002; 25: 1629-1633 (Pubitemid 39663683)
12. Pultrini Ade M, Galindo LA, Costa M. Effects of the essential oil from Citrus aurantium L. in experimental anxietymodels in mice. Life Sci 2006; 78: 1720-1725 (Pubitemid 43276479)
13. Oliva I, González-Trujano ME, Arrieta J, Enciso-Rodriguez R, Navarrete A. Neuropharmacological profile of hydroalcoholic extract of Valeriana edulis ssp. procera roots in mice. Phytother Res 2004; 18: 290-296 (Pubitemid 38619529)
14. Ugalde M, Reza V, González-Trujano ME, Avula B, Khan IA, Navarrete A. Isobolographic analysis of the sedative interaction between six central nervous system depressant drugs and Valeriana edulis hydroalcoholic extract in mice. J Pharm Pharmacol 2005; 57: 631-639 (Pubitemid 40562402)
15. Li C, Gu H, Dou H, Zhou L. Identification of flavanones from peel of Citrus changshan-huyou Y.B. Chang, by HPLC-MS and NMR. Eur Food Res Technol 2007; 225: 777-782
16. Hiller K, Zetler G. Neuropharmacological studies on ethanol extracts of Valeriana officinalis L.: behavioral and anticonvulsant properties. Phytother Res 1996; 10: 145-151
17. Tallarida R. Drug synergism and dose-effect data analisis. Boca Raton: Chapman and Hall/CRC Press; 2000: 21-35
18. Haapalinna A, Viitamaa T, MacDonald E, Savola JM, Tuomisto L, Virtanen R. Evaluation of the effects of a specific α2-adrenoceptor antagonist, atipamezole, on α1 and α2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine. Naunyn-Schmiedeberg's Arch Pharmacol 1997; 356: 570-582 (Pubitemid 27478959)
19. Warnick JE, Wicks RT, Sufka KJ. Modeling anxiety-like states: pharmacological characterization of chick separation stress paradigm. Behav Pharmacol 2006; 17: 581-587
20. Winter JC, Rabin RA. Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination. J Pharmacol Exp Ther 1992; 263: 682-689
21. Datta S, MacLean RR. Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence. Neurosci Biobehav Rev 2007; 31: 775-824 (Pubitemid 46670339)
22. Kuno N, Kamisaki Y, Itoh T. Inhibition of cyclic AMP accumulation by α2-adrenoceptors in the rat cerebral cortex. Eur J Pharmacol 1990; 176: 281-287 (Pubitemid 20076280)
23. Pauwels PJ, Van Gompel P, Leysen JE. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells. Biochem Pharmacol 1993; 45: 375-383 (Pubitemid 23042636)
24. Barnes PJ. Pharmacology of airway smooth muscle. Am J Respir Crit Care Med 1998; 158: S123-132
25. Ogasahara S, Taguchi Y, Wada H. Changes in the levels of cyclic nucleotides in rat brain during the sleep-wakefulness cycle. Brain Res 1981; 213: 163-171 (Pubitemid 11112849)
26. Zhang HT, O'Donnell JM. Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats. Psychopharmacology 2000; 150: 311-316
27. Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: mechanism of action, biochemical, metabolic and psychostimulant effects. Brain Res Rev 1992; 17: 139-170
28. Fredholm BB, Persson CGA. Xantine derivatives as adenosine receptor antagonist. Eur J Pharmacol 1982; 81: 673-676
29. Satoh S, Matsumura H, Hayaishi O. Involvement of adenosine A2A receptor in sleep promotion. Eur J Pharmacol 1998; 351: 155-162 (Pubitemid 28312926)
30. Ingkaninan K, Ijzerman AP, Verpoorte R. Leuteolin, a compound with adenosine A1 receptor-binding activity, and chromone and dihydronaphthalenone constituents from Senna siamea. J Nat Prod 2000; 63: 315-317 (Pubitemid 30173684)
31. Blardi P, De Lalla A, Volpi L, Di Perri T. Stimulation of endogenous adenosine release by oral administration of quercetin and resveratrol in man. Drugs Exp Clin Res 1999; 25: 105-110 (Pubitemid 29257601)